|
Regen Therapeutics PLC - Company Profile Snapshot
| Company Profile: |
Regen Therapeutics PLC |
| Ticker: |
RGT |
| Exchanges: |
LON |
| 2008 Sales: |
91,716 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
UNITED KINGDOM |
| Employees: |
7 |
Business Description
Regen Therapeutics PLC. The Group's principal activities are developing healthcare products both nutraceutical and ethical pharmaceuticals and conducting pharmacokinetic and pharmacodynamic research. Its operation focuses on the research and development of a drug product called Colostrinin for the treatment for Alzheimer's disease and other neurological disorders. Colostrinin is a proline-rich polypeptide complex derived from ovine and bovine colostrum. The Group operates solely in the United Kingdom.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
